In contrast, suprasellar CPs mainly disrupt hypothalamic function, leading to abnormal hypothalamic hormone secretion and pituitary stalk effects, and increased risk of CDI and hyperprolactinemia. This evidence concerns the gene CAD and hyperprolactinemia.